CVXL-0069

N/A

Report date: 2025/01/26 18:09:11
NME

Base Information

Drug NameCVXL-0069
Drug Alias Namedual adenosine A2A/A1 receptor antagonist (CleveXel Pharma)dual adenosine A2A/A1 receptor antagonist (CleveXel Pharma/Domain Therapeutics)dual adenosine A2A/A1 receptor antagonist (CleveXel Pharma/Kaldi Pharma)CVXL-0069
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdenosine A1 receptor antagonistsAdenosine A2a receptor antagonists
TargetsAdenosine A1 receptorAdenosine A2a receptor
Therapy Area/IndicationsParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesDomain Therapeutics SA
China Registration ClassN/A

Develop Information

Active CompaniesKaldi Pharma SASClevexel Pharma
Inactive CompaniesN/A
Active IndicationsParkinson Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A